Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity

Keyphrases

• Antigen Cross-presentation 25%
• Antigen Processing 25%
• Antigen-presenting Cells 25%
• Antigen-specific CD4 T Cells 25%
• Antigen-specific CD8+ T Cells 25%
• CD4+ T Cell Immunity 25%
• CD8+ T Cell Immunity 25%
• CD8+ T Cells 25%
• Clonal Expansion 25%
• Co-encapsulation 100%
• Cross-priming 25%
• Cytokine Secretion 25%
• Delivery Device 50%
• Endosomal 100%
• Endosomal Compartment 25%
• Exogenous Antigen 50%
• Immunogenicity 25%
• Infection Model 25%
• Live Vaccine 25%
• Live Vector 25%
• Poly(lactic-co-glycolic) 25%
• Processing Route 25%
• Protective Interventions 25%
• Receptor-based 25%
• Recombinant Antigen 25%
• Subunit Vaccine 25%
• T Cell Immunity 100%
• T Cell Vaccine 25%
• Therapeutic Intervention 25%
• Toll-like 75%
• Translocated 25%
• Tumor Model 25%
• Vaccination 25%

Immunology and Microbiology

• Adjuvant 100%
• Adoptive Immunity 100%
• Antigen Presentation 25%
• Antigen Specificity 25%
• Antigen-Presenting Cell 25%
• Cross-Presentation 50%
• Cytokine Release 25%
• Cytotoxic T-Cell 75%
• Immunogenicity 25%
• Maturation 25%
• Microsphere 100%
• Recombinant Antigen 25%
• Subunit Vaccine 25%
• T-Cell Vaccination 25%
• T-Helper Cell 50%
• TLR9 25%
• Toll-Like Receptor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Adjuvant 100%
• CD8 Antigen 75%
• Cytokine 25%
• Immunogenicity 25%
• Infection 25%
• Microsphere 100%
• Recombinant Antigen 25%
• Subunit Vaccine 25%
• Toll Like Receptor 50%
• Toll Like Receptor 7 25%
• Toll Like Receptor 9 25%
• Tumor Model 25%